|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Physiology and Developmental Biology, Brigham Young University, Provo, Utah, United States
2 Physiology and Developmental Biology, Brigham Young University, Provo, Utah, United States
* To whom correspondence should be addressed. E-mail: william_winder{at}byu.edu.
Skeletal muscle contraction results in the phosphorylation and activation of the AMP-activated protein kinase (AMPK) by an upstream kinase, AMPKK. The LKB1-STRAD-MO25 complex is the major AMPKK in skeletal muscle; however, LKB1-STRAD-MO25 activity is not increased by muscle contraction. This relationship suggests that phosphorylation of AMPK by LKB1-STRAD-MO25 during skeletal muscle contraction may be regulated by allosteric mechanisms. In this study we tested an array of metabolites including glucose-6-phosphate (G6P), fructose-6-phosphate (F6P), fructose 1,6-bisphosphate (F1,6-P2), 3-phosphoglycerate (3PG), glucose-1-phosphate (G1P), glucose-1,6-bisphosphate (G1,6-P2), adenosine diphosphate (ADP), carnitine (Carn), acetyl-carnitine (Acarn), inosine monophosphate (IMP), inosine, and ammonia for allosteric regulation. ADP inhibited both AMPK and LKB1-STRAD-MO25 actions, but probably is not important physiologically due to the low free ADP inside the muscle fiber. We found that 3PG stimulated LKB1-STRAD-MO25 activity and allowed for increased AMPK phosphorylation. 3PG did not stimulate LKB1-STRAD-MO25 activity toward the peptide substrate LKB1tide. These results have identified 3PG as an AMPK-specific regulator of AMPK phosphorylation and activation by LKB1-STRAD-MO25.
This article has been cited by other articles:
![]() |
V. Ljubicic and D. A. Hood Specific attenuation of protein kinase phosphorylation in muscle with a high mitochondrial content Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E749 - E758. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ljubicic and D. A. Hood Kinase-specific responsiveness to incremental contractile activity in skeletal muscle with low and high mitochondrial content Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E195 - E204. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cho, J. S. King, X. Qian, A. J. Harwood, and S. B. Shears Dephosphorylation of 2,3-bisphosphoglycerate by MIPP expands the regulatory capacity of the Rapoport-Luebering glycolytic shunt PNAS, April 22, 2008; 105(16): 5998 - 6003. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Jensen, A. J. Rose, S. B. Jorgensen, N. Brandt, P. Schjerling, J. F. P. Wojtaszewski, and E. A. Richter Possible CaMKK-dependent regulation of AMPK phosphorylation and glucose uptake at the onset of mild tetanic skeletal muscle contraction Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1308 - E1317. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |